Covered recipient · General Payments record
WILLIAM K MCDOWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$3,812.84
- Reported across 212 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.91 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $46.56 | 2 |
| Janssen Pharmaceuticals, Inc | $43.69 | 2 |
| Vanda Pharmaceuticals Inc. | $41.74 | 2 |
| Otsuka America Pharmaceutical, Inc. | $26.57 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.53 | 1 |
| Neurocrine BioSciences, Inc. | $16.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Indivior Inc. | $27.91 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562571 | CMS |
| Indivior Inc. | $18.65 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562573 | CMS |
| Janssen Pharmaceuticals, Inc | $17.61 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077976976 | CMS |
| Janssen Pharmaceuticals, Inc | $26.08 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077976968 | CMS |
| Neurocrine Biosciences, Inc. | $16.82 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150995810 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.57 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119134342 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.53 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151530239 | CMS |
| Vanda Pharmaceuticals Inc. | $23.48 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133957218 | CMS |
| Vanda Pharmaceuticals Inc. | $18.26 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133957220 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.